The leukemic matrisome interface as a source of markers and targets for acute myeloid leukemia - ELMI is a research consortium led by Prof. Taina Pihlajaniemi (University of Oulu), Prof. Jyrki Heino (Univ. of Turk) and Adj. Prof. Valerio Izzi (University of Oulu), with important collaborative contributions by Ass. Prof. Alexandra Naba (Univ. of Illinois at Chicago), Prof. Caroline Heckman, (Institute for Molecular Medicine Finland - FIMM), Prof. Simon Méndez-Ferrer (Cambridge School of Medicine), Adj. Prof. Katri Pylkäs (University of Oulu), and the personnel of Oulu University Hospital. It is funded by the Academy of Finland Molecular Regulatory Networks of Life (R'Life) program for the years 2020 - 2023.
The official kick-off meeting and first steering group meeting is held at the University of Oulu, Faculty of Biochemistry and Molecular Medicine, on 16.1.2020.
Last updated: 15.1.2020